Sujit Kumar Debnath
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Inhalation and Respiratory Drug Delivery 5
- Cystic Fibrosis Research Advances 2
-
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 3
- Co-authors
- Rohit Srivastava (14 shared papers)Abdelwahab Omri (7 shared papers)S. Saisivam (4 shared papers)Ajit R. Kulkarni (1 shared paper)Rajendra Prasad (2 shared papers)Daphika S. Dkhar (1 shared paper)Rohini Kumari (1 shared paper)Vikas Dighe (1 shared paper)
In The Last Decade
Sujit Kumar Debnath
21 papers receiving 427 citations
Peers
Comparison fields: 5 of 92
- Pharmaceutical Science 95
- Biomaterials 87
- Molecular Medicine 18
- Pulmonary and Respiratory Medicine 99
- Biomedical Engineering 131
Countries citing papers authored by Sujit Kumar Debnath
This map shows the geographic impact of Sujit Kumar Debnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujit Kumar Debnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujit Kumar Debnath more than expected).
Fields of papers citing papers by Sujit Kumar Debnath
This network shows the impact of papers produced by Sujit Kumar Debnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujit Kumar Debnath. The network helps show where Sujit Kumar Debnath may publish in the future.
Co-authors
The 14 scholars most cited alongside Sujit Kumar Debnath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 142 | |
| 2 | 2018 | 84 | |
| 3 | 2017 | 51 | |
| 4 | 2024 | 23 | |
| 5 | 2022 | 21 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 15 | |
| 8 | 2017 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 9 | |
| 12 | 2024 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2015 | 4 | |
| 17 | 2010 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 2 |
About Sujit Kumar Debnath
Sujit Kumar Debnath is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Biomedical Engineering, Biomaterials and Materials Chemistry, having authored 21 papers that have together received 437 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (5 papers), Advanced Drug Delivery Systems (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Drug Solubulity and Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (3 papers), Quantum Dots Synthesis And Properties (2 papers), Pesticide Residue Analysis and Safety (2 papers) and Cystic Fibrosis Research Advances (2 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Biomaterials (87 citations), Molecular Medicine (18 citations), Pulmonary and Respiratory Medicine (99 citations) and Biomedical Engineering (131 citations). Sujit Kumar Debnath has collaborated with scholars based in India, Canada and Australia. Frequent co-authors include Rohit Srivastava, Abdelwahab Omri, S. Saisivam, Ajit R. Kulkarni, Rajendra Prasad, Daphika S. Dkhar, Rohini Kumari, Vikas Dighe, Pranjal Chandra and Ananya Srivastava. Their work appears in journals such as PLoS ONE, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, Expert Review of Anti-infective Therapy, Expert Opinion on Emerging Drugs and AIDS and Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.